TALi Digital Limited Stock

Equities

TD1

AU0000074221

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:15 2024-05-22 am EDT 5-day change 1st Jan Change
0.002 AUD +33.33% Intraday chart for TALi Digital Limited 0.00% +100.00%
Sales 2022 881K 584K Sales 2023 781K 518K Capitalization 4.94M 3.28M
Net income 2022 -6M -3.98M Net income 2023 -2M -1.33M EV / Sales 2022 6.81 x
Net cash position 2022 1.34M 890K Net cash position 2023 2.48M 1.65M EV / Sales 2023 3.15 x
P/E ratio 2022
-0.86 x
P/E ratio 2023
-1.36 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 45.85%
More Fundamentals * Assessed data
Dynamic Chart
1 day+33.33%
Current month+33.33%
3 months+100.00%
6 months+100.00%
Current year+100.00%
More quotes
1 week
0.00
Extreme 0.001
0.00
1 month
0.00
Extreme 0.001
0.00
Current year
0.00
Extreme 0.001
0.00
1 year
0.00
Extreme 0.001
0.00
3 years
0.00
Extreme 0.001
0.06
5 years
0.00
Extreme 0.001
0.11
10 years
0.00
Extreme 0.001
0.54
More quotes
Managers TitleAgeSince
Sales & Marketing - 20-03-24
Corporate Secretary - 22-12-04
Sales & Marketing - 20-03-24
Members of the board TitleAgeSince
Chairman 54 16-08-31
Director/Board Member 63 20-06-28
Director/Board Member - 22-10-17
More insiders
Date Price Change Volume
24-05-22 0.002 +33.33% 6,000
24-05-21 0.0015 -25.00% 48,844
24-05-20 0.002 0.00% 71,419
24-05-16 0.002 +100.00% 935,466

Delayed Quote Australian S.E., May 22, 2024 at 02:10 am EDT

More quotes
Tali Digital Ltd is a digital health company. The Company is focused on delivering diagnostic and therapeutic solutions to enhance attention and overall cognitive function. The Company has built a patented platform technology with the programs targeting cognitive attention skills during early childhood via an evidence-based screening tool (DETECT) incorporated into training modules (TRAIN, ReadyAttentionGo! and AttentionTime!). ReadyAttentionGo is an Australian medical device that is a digital therapeutic cognitive training program specifically designed to improve attention skills in children aged three-ten years. The product consists of an app where a child plays a series of digital games to improve attention skills, and a Web portal where a healthcare provider can gain vital insights into selective, sustained, and executive attention domains. It also delivers a series of product developments relevant to attention deficit hyperactivity disorder and autism spectrum disorder.
More about the company